J&J Unit To Shell Out $85M Over Bad Natrecor Labeling
Johnson & Johnson subsidiary Scios Inc. agreed Wednesday to pay $85 million to settle criminal charges in California that it failed to provide adequate usage directions for heart failure drug Natrecor....To view the full article, register now.
Already a subscriber? Click here to view full article